GlassScriptPhysician profile
Mohammed U Shaikh
NPI 1952696635
$13,980.34
in general payments reported to CMS, 2019-2025
43 companies · $1,192 in 2025
The $1,192 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,956 · 2020: $938 · 2021: $880 · 2022: $3,639 · 2023: $995 · 2024: $3,381 · 2025: $1,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,713 · Travel and Lodging: $768 · Entertainment: $47.37 · Education: $39.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,712.69 |
| Travel and Lodging | $767.62 |
| Entertainment | $47.37 |
| Education | $39.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,788.57 | 2019-2025 | Proclaim, Eterna, Mitraclip |
| Painteq LLC | $1,707.73 | 2022-2023 | Painteq |
| Medtronic USA, INC. | $1,683.78 | 2019-2020 | |
| Boston Scientific Corporation | $1,485.03 | 2019-2025 | Wavewriter Alpha Prime 16, General - Dbs, Clinical Trial Product |
| Medtronic, INC. | $1,265.59 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Foundation Fusion Solutions, LLC | $906.74 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $436.86 | 2019-2024 | Belbuca |
| Vertos Medical, INC. | $354.06 | 2023-2024 | Mild Device Kit |
| Averitas Pharma INC. | $279.43 | 2023-2024 | Qutenza |
| Sentynl Therapeutics, INC. | $171.87 | 2019 | |
| Nevro Corp. | $134.19 | 2019-2020 | |
| Assertio Therapeutics, INC. | $130.98 | 2019-2020 | |
| Pfizer INC. | $128.40 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $124.51 | 2020 | |
| Spinal Simplicity, LLC | $120.24 | 2021-2025 | Ha Minuteman G3-R |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $113.24 | 2019-2025 | |
| Spr Therapeutics, INC | $110.22 | 2019-2024 | Sprint Pns System |
| Ge Healthcare | $96.16 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $95.23 | 2019-2020 | |
| Si-Bone, INC. | $81.66 | 2021-2024 | |
| Scilex Pharmaceuticals INC. | $60.28 | 2021-2022 | |
| Curonix LLC | $55.67 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Forte Bio-Pharma LLC | $51.74 | 2020-2024 | Prolate, Nalocet |
| Nalu Medical, INC. | $49.50 | 2022 | |
| Amgen INC. | $49.05 | 2021-2022 | |
| Lilly USA, LLC | $48.82 | 2019-2022 | |
| Relievant Medsystems, INC. | $42.25 | 2022-2023 | Intracept |
| Bioventus LLC | $41.49 | 2019-2024 | Gelsyn-3 |
| Saluda Medical Americas, INC. | $41.21 | 2025 | Evoke |
| Stimwave Technologies Incorporated | $40.60 | 2020-2022 | |
| Abbvie INC. | $38.84 | 2021-2023 | Botox |
| Mml US, INC. | $33.56 | 2023 | Reactiv8 |
| Avanos Medical | $31.73 | 2020-2023 | Generator |
| Zyla Life Sciences, INC. | $24.60 | 2020 | |
| Stratus Medical, LLC | $23.51 | 2022 | |
| Redhill Biopharma INC. | $22.66 | 2021 | |
| Almatica Pharma LLC | $22.28 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.66 | 2019 | |
| Valinor Pharma, LLC | $16.62 | 2023 | Movantik |
| Arbor Pharmaceuticals, INC. | $14.53 | 2019 | |
| Vertiflex, INC. | $13.40 | 2019 | |
| Athena Bioscience, LLC | $8.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$377,894.84 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Shaikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.